▲ Peaking
Business
Genmab’s latest phase 2 data spur claim ADC is ‘clearly superior’ to AbbVie’s Elahere
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
1 trends tracked about this subject — the full history, oldest to newest below.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.